These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16941469)

  • 1. Spinocerebellar ataxia type 1, 2, and 3 and restless legs syndrome: striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography.
    Reimold M; Globas C; Gleichmann M; Schulze M; Gerloff C; Bares R; Machulla HJ; Bürk K
    Mov Disord; 2006 Oct; 21(10):1667-73. PubMed ID: 16941469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.
    Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Cselényi Z; Matthews JC; Lai RY; Halldin C; Farde L
    Brain; 2006 Aug; 129(Pt 8):2017-28. PubMed ID: 16816393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
    Turjanski N; Lees AJ; Brooks DJ
    Neurology; 1999 Mar; 52(5):932-7. PubMed ID: 10102408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
    Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients.
    Kim KW; Jhoo JH; Lee SB; Lee SD; Kim TH; Kim SE; Kim YK; Yoon IY
    Eur J Neurol; 2012 Sep; 19(9):1213-8. PubMed ID: 22435397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCA 1, SCA 2 & SCA 3/MJD mutations in ataxia syndromes in southern India.
    Krishna N; Mohan S; Yashavantha BS; Rammurthy A; Kiran Kumar HB; Mittal U; Tyagi S; Mukerji M; Jain S; Pal PK; Purushottam M
    Indian J Med Res; 2007 Nov; 126(5):465-70. PubMed ID: 18160752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machado-Joseph disease and other rare spinocerebellar ataxias.
    Matilla-Dueñas A
    Adv Exp Med Biol; 2012; 724():172-88. PubMed ID: 22411243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
    Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride.
    Montgomery AJ; Stokes P; Kitamura Y; Grasby PM
    J Affect Disord; 2007 Aug; 101(1-3):113-22. PubMed ID: 17197036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.
    Kim JM; Hong S; Kim GP; Choi YJ; Kim YK; Park SS; Kim SE; Jeon BS
    Arch Neurol; 2007 Oct; 64(10):1510-8. PubMed ID: 17923635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients.
    Maruyama H; Izumi Y; Morino H; Oda M; Toji H; Nakamura S; Kawakami H
    Am J Med Genet; 2002 Jul; 114(5):578-83. PubMed ID: 12116198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary ataxias.
    Evidente VG; Gwinn-Hardy KA; Caviness JN; Gilman S
    Mayo Clin Proc; 2000 May; 75(5):475-90. PubMed ID: 10807077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
    Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
    J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis and application of SCA1 and SCA3/MJD gene CAG repeats in Han population in Northeastern China].
    Jiang M; Jin CL; Lin CK; Qiu GR; Liu ZL; Wang CX; Sun KL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):83-5. PubMed ID: 14767919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3.
    Abele M; Bürk K; Laccone F; Dichgans J; Klockgether T
    J Neurol; 2001 Apr; 248(4):311-4. PubMed ID: 11374096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased synaptic dopamine in the putamen in restless legs syndrome.
    Earley CJ; Kuwabara H; Wong DF; Gamaldo C; Salas RE; Brašić JR; Ravert HT; Dannals RF; Allen RP
    Sleep; 2013 Jan; 36(1):51-7. PubMed ID: 23288971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.